AI English summary of an SEC filing — figures as filed
The company said RPO was $17.7 billion as of March 31, 2024, of which 48% was cRPO. RPO and cRPO rose 26% and 21%, respectively, compared to March 31, 2023.
Key points
AI summaryThe company said RPO was $17.7 billion as of March 31, 2024, of which 48% was cRPO. RPO and cRPO rose 26% and 21%, respectively, compared to March 31, 2023.
ServiceNow said operating cash flow for Q1 2024 (3 months) was $1,341 million, up from $902 million a year earlier. The company cited higher collections from revenue growth as the driver of the increase.
The company said research and development expenses rose $114 million from a year earlier for Q1 2024 (3 months). It cited an increase in personnel-related costs, including stock-based compensation and overhead, of $98 million due to higher headcount as the main driver.
The company said it repurchased 0.2 million shares of common stock on the open market for $175 million during the 3 months of Q1 2024. The program, approved in May 2023 with a maximum of $1.5 billion, had about $787 million remaining as of March 31, 2024.
Key figures
Quarter ended March 31, 2024
- Revenue
- $2.6B
- Operating income
- $332M
- Net income
- $347M
- EPS
- $1.67
- Gross profit
- $2.1B
- Operating cash flow
- $1.3B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
RPO at $17.7 billion, cRPO share at 48%
The company said RPO was $17.7 billion as of March 31, 2024, of which 48% was cRPO. RPO and cRPO rose 26% and 21%, respectively, compared to March 31, 2023.
Source · Based on the MD&A text of the filing
Operating cash flow at $1,341 million
ServiceNow said operating cash flow for Q1 2024 (3 months) was $1,341 million, up from $902 million a year earlier. The company cited higher collections from revenue growth as the driver of the increase.
Source · Based on the MD&A text of the filing
R&D expenses up $114 million
The company said research and development expenses rose $114 million from a year earlier for Q1 2024 (3 months). It cited an increase in personnel-related costs, including stock-based compensation and overhead, of $98 million due to higher headcount as the main driver.
Source · Based on the MD&A text of the filing
Share repurchases of $175 million
The company said it repurchased 0.2 million shares of common stock on the open market for $175 million during the 3 months of Q1 2024. The program, approved in May 2023 with a maximum of $1.5 billion, had about $787 million remaining as of March 31, 2024.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…